Add to Favourites
To login click here
The global drug discovery informatics market is expected to reach USD 1 million by 2030, with a CAGR of 9.0% during the forecast period. The market is driven by factors such as the desire for tailored treatment, growing investment in pharmaceutical R&D, and technological improvements. The use of machine learning and artificial intelligence in drug development procedures, along with big data analytics and cloud computing, has greatly improved data processing skills and streamlined the drug development pipeline. The market is also boosted by regulatory backing and partnerships between pharmaceutical firms and informatics providers.